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Background: Localization of mRNAs encoding cytoskeletal or signaling proteins to neuronal processes is known to
contribute to axon growth, synaptic differentiation and plasticity. In addition, a still increasing spectrum of mRNAs
has been demonstrated to be localized under different conditions and developing stages thus reflecting a highly
regulated mechanism and a role of mRNA localization in a broad range of cellular processes.
Results: Applying fluorescence in-situ-hybridization with specific riboprobes on cultured neurons and nervous
tissue sections, we investigated whether the mRNAs for two metabolic enzymes, namely glycogen synthase (GS)
and glycogen phosphorylase (GP), the key enzymes of glycogen metabolism, may also be targeted to neuronal
processes. If it were so, this might contribute to clarify the so far enigmatic role of neuronal glycogen. We found
that the mRNAs for both enzymes are localized to axonal and dendritic processes in cultured lumbar spinal
motoneurons, but not in cultured trigeminal neurons. In cultured cortical neurons which do not store glycogen but
nevertheless express glycogen synthase, the GS mRNA is also subject to axonal and dendritic localization. In spinal
motoneurons and trigeminal neurons in situ, however, the mRNAs could only be demonstrated in the neuronal
somata but not in the nerves.
Conclusions: We could demonstrate that the mRNAs for major enzymes of neural energy metabolism can be
localized to neuronal processes. The heterogeneous pattern of mRNA localization in different culture types and
developmental stages stresses that mRNA localization is a versatile mechanism for the fine-tuning of cellular events.
Our findings suggest that mRNA localization for enzymes of glycogen metabolism could allow adaptation to spatial
and temporal energy demands in neuronal events like growth, repair and synaptic transmission.
Keywords: Energy metabolism, Fluorescence in-situ hybridization, Glycogen phosphorylase, Glycogen synthase,
mRNA localization, Neuronal primary cultureBackground
Neurons are highly polarized cells and mRNA localization
to dendritic and axonal processes and local protein
synthesis provide a means for the spatial and temporal
fine-tuning of cellular events. Triggered by extrinsic
signals, local translation of mRNAs can mediate growth,
navigation and synapse formation in growing axons and
dendrites as well as metabolic maintenance and repair in* Correspondence: ralf.jansen@uni-tuebingen.de
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article, unless otherwise stated.mature cells (for overview, see [1,2]). Studies with injured
and uninjured axons of CNS neuronal cultures revealed
the prevalence of mRNAs related to axonal guidance and
synaptic function in regenerating neurons, while those for
components of intracellular transport, mitochondria and
cytoskeleton were more abundant in uninjured neurons
[3]. In axons from explant cultures of embryonic and adult
sensory neurons, microarray analysis revealed a repertoire
of about 3000 localized mRNAs which changed signifi-
cantly during development from embryonic to adult [4].
In cultures of rat sympathetic neurons, the mRNA for
Impa1, a key-enzyme of the inositol signaling pathway,d Central Ltd. This is an Open Access article distributed under the terms of the
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[5]. The spectrum of mRNAs localized to axons also com-
prises mRNAs encoding enzymes of energy and carbohy-
drate metabolism, e.g. enolase, phosphoglycerate kinase
and glucose-6-phosphate dehydrogenase [4], indicating a
functional role of mRNA localization also in basic meta-
bolic pathways. Among the mRNAs present only in axons
of embryonic cultures were also those for glycogenin 1
and the brain isoform of glycogen phosphorylase [4].
Glycogen represents the major brain energy reserve
which is located mainly in astrocytes [6]. Though its
precise functions are still under debate, it has been pro-
posed to be an emergency fuel store during physiological
and pathological stress such as hypoglycemia and cerebral
ischemia [7-9], but there is evidence for a role of glycogen
also in normal metabolism, e.g. in learning and memory
[10]. In the astrocyte-neuron lactate shuttle hypothesis
(ANLSH), lactate derived from astrocytic glycogen and
trafficking to adjacent neurons has been attributed a
major role in brain energy metabolism [11]. In contrast
to the CNS, the role of glycogen in the PNS has only
recently been studied [12].
Because of the metabolic instability of glycogen, the
presence of the key enzymes of glycogen metabolism,
glycogen phosphorylase (GP) and glycogen synthase
(GS), could serve as an indicator for glycogen, though
this does not necessarily prove its presence. Applying GP
isozyme-specific antibodies on rat tissue sections, it could
be demonstrated that astrocytes express the muscle (MM)
as well as the brain (BB) isozyme of glycogen phosphoryl-
ase while cortical neurons are devoid of immunoreactivity
for both isoforms [13]. Neurons of the PNS, however,
but also large motoneurons of the spinal cord express
the BB isoform only [13-15]. Remarkably, GPBB is not
only present in the cell soma, but also in the axons of
spinal and vagus nerves, proposing a special role for
glycogen in peripheral nerves. The presence of GP protein
in peripheral axons with their appreciable length raises
the question for a possible trafficking of its mRNA instead
of the transport of the protein. This would be favorable,
because it would endow the axon with the autonomy for
local GP synthesis and thereby meet the special energy
needs e.g. in growing and regenerating axons.
To study a possible axonal and dendritic localization
of the mRNAs for GP and GS, we visualized the
mRNAs with fluorescence in-situ hybridization (FISH)
on three types of cultured neurons: Spinal motoneu-
rons (motoneuron culture, MNC), cortical neurons
(neuronal primary culture, NPC) and trigeminal neurons
(trigeminal neuron culture, TNC). To compare FISH
results on cultured cells with mRNA distribution pat-
terns in situ, FISH was also applied on tissue sections. To
investigate whether, in addition to GS, GP is also expressed
in cortical neurons, the expression rates of GP mRNA andprotein in NPC were determined by qRT-PCR and Western
blot analysis.
Methods
All experiments involving animals were carried out
according to the law of animal experimentation issued
by the German parliament (“Tierschutzgesetz”) and to
the European Communities Council Directive. The
present study was approved on May 16 2012, by the
Regierungspräsidum Tübingen (Baden-Württemberg,
Germany) according to § 4, Abs.3 of the law of animal
experimentation.
Cell cultures
For all experiments, we used standard protocols established
and routinely applied in our labs. All cultures were immu-
nocytochemically characterized using established markers.
NPC were prepared from ED 16 Wistar rat brains.
Shortly, brains were dissected from the embryos and
collected in Hibernate-E Medium (life technologies,
Darmstadt, Germany) supplemented with B27 supplement
and GlutaMAX (life technologies). Brains were mechanic-
ally dissociated by passing them through a nylon cloth of
110 μm mesh size. After centrifugation at 400 g and 4°C
for 10 min, the cell pellet was resuspended in Neurobasal
Medium (life technologies) supplemented as above. The
cell suspension was passed through a second nylon cloth
of 25 μm mesh size, appropriately diluted and seeded
at a density of 1–3 million cells/ 21 cm2 surface area in
5 ml medium on p-D-lysine-coated coverslips. Cells were
cultured at 37°C and 5% CO2 in a humidified atmosphere.
For all experiments, 4–7 DIV cultures were used. Astro-
glial primary cultures (APC) were prepared from newborn
Wistar rat brains as described [16]. For isolation of RNA
and preparation of homogenates for Western blotting, 10
DIV cultures were used.
Studies on GP had primarily been carried out with rat
tissues and primary cultures derived from rat brain, but
studies carried out with tissues and cultures from other
species confirmed the results [17,18]. We therefore used
mouse spinal motoneuron and trigeminal neuron cultures
for FISH analysis in motoneurons and trigeminal neurons.
MNC were prepared from the lumbar spinal cords of ED
13.5 Bl/6 mice as described [19] and used for experiments
after 5 DIV. TGC were prepared from the trigeminal gan-
glia of PD 0–5 or ED 16.5 CD1 mice as described [20] and
used for experiments after 3–7 DIV.
Tissue sections and immunohistochemistry (IHC)
Tissues were freshly dissected from adult Wistar rats of
both sexes (4 animals for spinal cord sections, 3 animals
for trigeminal ganglion sections, 2 animals for ventral
spinal nerve and trigeminal nerve sections, respectively)
and fixed in 4% paraformaldehyde/phosphate-buffered
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tissue was frozen by immersion in liquid nitrogen. Sections
were cut at 10 μm and stored at −80°C until processed.
Riboprobe preparation
Total RNA was isolated from whole rat brain using TRI
Reagent Solution (Ambion, Life Technologies) according
to the manufacturer’s protocol. About 1 μg of total RNA
was reversely transcribed using Oligo(dT) primers and
2 μl of the resulting cDNA solution were used as a
template for the PCR amplification of nucleotide se-
quences from the coding regions of rat glycogen synthase
1 (accession number BC 131849) and rat brain glycogen
phosphorylase (accession number NM 0131188). The
following primers were used: GS, forward primer 5′-
AGCCATCTTTGCGACTCAGC-3′, reverse primer 5′-
TGGTAGGACTCAGGGGCTCA-3′; GP, forward primer
5′-TCCCAGACAAGGTAGCCATC-3′, reverse primer 5′-
AAGGCCTCATCATCAACCAG-3′. The PCR products
were diluted 1:10 and used as templates for a second PCR
amplification applying primers including sequences of
the T7 and SP6 RNA polymerase promoters, respectively.
Primers were the following: GS, forward primer SP6,
5′-ATTTAGGTGACACTATAGACACCCTCACTGTC
TCGACAC-3′, reverse primer T7 5′- TAATACGACT
CACTATAGGGTGTACTGAGTGAGCTGGAGG-3′; GP,
forward primer SP6 5′-ATTTAGGTGACACTATAGATC
CCAGACAAGGTA-3′, reverse primer, T7 TAATACGAC
TCACTATAGGAAGGCCTCATCATCACC-3′. The prod-
ucts from 5 PCRs were pooled and purified. For GS
DNA, electrophoresis in a 1% agarose preparative gel
with subsequent extraction using a gel extraction kit
(QIAGEN, Stockach, Germany) according to the man-
ufacturer’s protocol was applied; GP DNA was purified
with a PCR purification kit (QIAGEN) according to the
manufacturer’s protocol.
Digoxigenin(DIG)-labeled RNA probes were prepared
by in-vitro transcription with T7 RNA polymerase
(antisense probe) or SP6 RNA polymerase (sense probe),
respectively, using a DIG RNA Labeling Kit (Roche,
Mannheim, Germany) according to the manufacturer’s
protocol. The length of the transcripts was checked by
agarose gel electrophoresis, subsequent capillary transfer
to a nylon membrane and visualization of the bands
with an alkaline phosphatase-coupled DIG antibody
and nitroblue tetrazolium chloride/5-bromo-4-chloro-
indolylphosphate substrate reaction. The lengths of the
riboprobes were approximately 250 nt for GS and 600 nt
for GP. Dot blots were used for semi-quantitative analysis
of the probe concentrations.
Fluorescence in-situ hybridization
After defined periods of time in culture, cells were fixed
in 4% PFA/PBS at 4°C for 10 min, then washed with PBSand subsequently permeabilized with PBS/0.3% Triton
X-100 at RT for 10 min. After a washing step in PBS, cells
were pre-hybridized at 55°C for 0.5 – 2 h in the following
hybridization buffer: 4x saline-sodium citrate (SSC), 4x
Denhardt’s, 10% dextrane sulfate, 500 μg/ml salmon sperm
DNA, 250 μg yeast tRNA and 50% formamide. Probes were
denatured at 90°C for 5 min. Hybridization was performed
in hybridization buffer at 55°C overnight with a probe con-
centration of 5 ng/μl for MNC and 0.1 ng/μl for the other
cultures. Stringency washes were performed with 0.2x SSC
at 55°C for MNC and 72°C for other culture types for
1 h and then with 0.2x SSC at room temperature (RT)
for 5 min. After a blocking step in 0.5% Blocking Reagent
(Roche) at RT for 30 min, cells were incubated with sheep
anti-DIG peroxidase (POD) conjugate (Fab-fragments,
Roche) diluted 1:500 in blocking reagent at RT for 3 h. After
two washing steps in 0.1 M Tris/HCl, 0.15 M NaCl pH 7.5,
0,05% Tween 20 cells were incubated with the TSA-Plus
Fluorescein reagent (Perkin Elmer, Rodgau-Jügersheim,
Germany), diluted 1:50 (MNC) or 1:100 (other cell types)
for 10 min (MNC) or 30 min (other cell types). After two
washing steps, cells were rinsed with water and embedded
in Immumount. Negative controls included replacement
of antisense probe by sense probe, omitting of probes and
omitting of anti-DIG antibody. In experiments combining
FISH with immunocytochemistry (ICC), the relevant
primary antibody was incubated together with the anti-
DIG/POD conjugate. After the washing steps, cells were
incubated with the secondary antibody diluted 1: 1000
at RT for 1 h. For FISH on tissue slices, the protocol was
essentially the same with the following exceptions: Sections
were postfixed in ice-cold 4% PFA/PBS for 5 min, and after
stringency washes, endogenous peroxidase was blocked by
incubation in 2% H2O2/1x SSC at RT for 15 min. Images
were acquired with a Zeiss Cell Observer microscope using
a 40x oil immersion objective and AxioVision software.
Immunostaining on tissue sections and NPC that was not
combined with FISH was performed as described [13], with
the exception that secondary antibodies were conjugated to
Alexa Dye 488 or 568 and diluted 1:1000. For TGC, the
staining protocol was essentially identical. In brief, unspecific
binding was blocked by incubation in 5% donkey serum/
PBS for 30 min prior to incubation with antisera. All anti-
bodies were diluted in 1% donkey serum; GP immunostain-
ing was combined with staining for β-tubulin (1:2000) at RT
for 2 h. Secondary antibodies were conjugated to Alexa dye
488 (anti-rabbit) or Cy5 (anti-mouse), diluted 1:500 and
applied at RT for 30 min. Nuclei were stained with 4′,6-
diamidino-2-indole (DAPI) diluted 1:10 000 in PBS .
qRT-PCR
Total RNA was isolated from NPC, APC, rat cortex and
cerebellum using TRI-Reagent (Ambion) according to
the manufacturer’s protocol. After DNase treatment
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of RNA were reversely transcribed applying the High
Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Life Technologies). For PCR reactions, 3.1 ng
of cDNA were used. Reactions were prepared with Fast
SYBR Mix (Applied Biosystems) and the following primers:
GP, forward primer 5′- TCAGGGATGTAGCCAAGGTC-
3′, reverse primer 5′-TCGGTTGTACAGGGTGATGA-3′;
GS, forward primer 5′-CCCCCAATGGACTAAATGTG-
3′, reverse primer 5′-AGCGTCCAGCGATAAAGAAA-3′;
GFAP, forward primer 5′- GAAGAAAACCGCATCACC
AT-3′, reverse primer 5′-TCCTTAATGACCTCGCCATC-
3′; GAPDH, forward primer 5′-CTCATGACCACAGTCC
ATGC-3′, reverse primer 5′-TTCAGCTCTGGGATGA
CCTT-3′; β-actin, forward primer 5′-AGCCATGTACGT
AGCCATCC-3′, reverse primer 5′-ACCCTCATAGATGG
GCACAG-3′; 18S rRNA, forward primer 5′-GCAATTAT
TCCCCATGAACG-3′, reverse primer 5′-GGCCTCACT
AAACCATCCAA-3′. All PCR reactions were performed
in triplicate and repeated at least 6 times. Each experiment
included a no-reverse transcription control and a no-
template control. Amplification efficiencies were tested
for each gene and reached optimal values (>1.8). Ct values
were normalized to GAPDH, β-actin and 18S rRNA. Ex-
pression rates were expressed as n-fold of the expression
rate of the relevant gene in APC.
Western blot analysis
Western blotting was performed as described [13] with
the following exceptions: proteins were transferred to a
PVDF membrane using a semi-dry blotting system (BioRad,
München, Germany). After a blocking step, the membrane
was incubated with goat anti-rabbit IgG/POD conjugate
(diluted 1:10 000) at RT for 2 h. The blot was developed
applying a chemiluminescence detection system (ECL
Western Blotting Substrate (Pierce, Rockford, IL, USA).
Antibodies
Rabbit antiserum against rat brain glycogen phosphorylase
isozyme was generated as published [13]. Anti-MAP2
monoclonal antibody was purchased from Millipore
(Darmstadt, Germany). Rabbit antiserum against tau
and monoclonal antibodies against GFAP and GAP-43
were from Sigma/Aldrich (St. Louis, MO, USA). Donkey
antiserum against β-tubulin was purchased from Covance
(Princeton, NJ, USA). Fluorescent secondary antibodies
were from Molecular probes (Invitrogen), goat anti-rabbit
POD conjugate was from Jackson Immuno Research
(Dianova, Hamburg, Germany).
Results
GP and GS FISH on cultured lumbar motoneurons
To study the mRNA expression of GP and GS, the key
enzymes of glycogen metabolism, we applied FISH oncultured spinal motoneurons. This also allowed us to inves-
tigate the distribution of these mRNAs in soma, dendrites
and axons. GP mRNA was present in the cell soma as well
as in processes (Figure 1a, d, arrows). The signal overlapped
with the signal for MAP2 (Figure 1b,c) as well as that for
tau (Figure 1e, f) indicating the presence of the mRNA in
dendrites as well as in axons. GP protein was also detect-
able in somata and processes (Figure 1g-i). As a specific
control, applying GP sense probe instead of antisense re-
sulted in only minimal color development (Figure 1j, k). GS
mRNA was also localized to the processes and matched the
patterns of MAP2 (Figure 1l-n) and tau (Figure 1o-q).
GP FISH and IHC on spinal cord sections
We then went on to study the distribution of GP mRNA
and protein in vivo in tissue sections. In cross-sections
of lumbar spinal cord, GP protein as well as the mRNA
were detectable in large motoneurons (Figure 2a,d); the
mRNA signal was also visible in the proximal segments
of thick processes (arrow Figure 2d). Interestingly, in
cross-sections of the ventral spinal root, GP protein was
abundant in the axons whereas no mRNA was detectable
(Figure 2b, e). GS mRNA showed the same distribution
pattern as GP mRNA (not shown).
GS and GP FISH on cultured cortical neurons
Based on the finding that GP and GS mRNAs are localized
to the processes in cultured motoneurons, we then studied
GS and GP mRNA expression in cultured cortical neurons.
FISH experiments were performed on DIV 4 to DIV 7 cul-
tures and displayed no culture time-dependent differences.
GS mRNA was detectable in cultured cortical neurons and
colocalized with the dendritic marker MAP2 (Figure 3a-c),
and the axonal marker tau (Figure 3d-f). The signal was
visible in the cell soma and the processes. Higher magnifi-
cation (boxed areas 1 and 2 in c and f) revealed a granular
appearance of mRNA in the processes (Figure 3d-f). As an
additional neuronal marker, we used GAP 43 (Figure 3g-i).
GS mRNA as well as GAP 43 were present in the axon,
though direct overlap of the signals in growth cone-like
structures was not obvious. Applying the sense probe
resulted in a signal of neglectible intensity compared to
that detected with the antisense probe (Figure 3j-l).
In contrast to GS, the GP FISH signal was low and
could only be detected in the soma and in the very prox-
imal parts of neuronal processes (Figure 4a-c). The sig-
nal was higher in comparison to the signal level with the
relevant sense probe (Figure 4d-f ), but the difference
was not significant enough to allow unambiguous con-
clusions. Astrocytes contaminating NPC did not express
GP mRNA (arrows in Figure 4g-i). Immunocytochemical
staining for GP protein in neuronal cultures revealed a
weak signal (Figure 4j). However, the signal displayed
when replacing GP antiserum by rabbit normal serum
Figure 1 FISH detection of GP and GS mRNA in spinal motoneurons, 5 DIV. GP mRNA colocalizes with MAP 2 (a-c) and tau (d-f). Arrows in
a and d point to mRNA localized to neuronal processes. The signals for GP mRNA and protein are congruent (g-i). j, k Negative control applying
GP sense probe instead of antisense. j FISH, k FISH combined with Nomarski optics. GS mRNA also colocalizes with MAP 2 (l-n) and tau (o-q). Bar
in a = 20 μm and applies to a-q.
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the detected signal was due to unspecific binding of the
antibody. The results of FISH and ICC/IHC studies are
summarized in Table 1.
qRT-PCR and Western blotting
Because the results from FISH as well as from immuno-
cytochemistry concerning the presence of GP mRNA andprotein in NPC were difficult to interpret, we performed
qRT-PCR and Western blotting. We compared the amounts
of GP and GS mRNA in NPC by qRT-PCR (Figure 5a) to
those in brain regions and expressed them as n-fold of the
mRNA present in astroglial cultures that are known to store
glycogen and to express GP and GS. GP mRNA was clearly
detected in NPC and reached 86% of the level found in cor-
tex and 72% of the level found in cerebellum. GP mRNA
Figure 2 GP IHC and FISH applied on sections of lumbar spinal cord and ventral spinal nerve. GP protein is prominent in large motoneurons
(a) and the axons of the ventral root of the spinal nerve (b). Occasional signal can be detected in Schwann cells, but this is also the case in the negative
control applying non-immune serum instead of immune serum (c). GP mRNA is mainly present in the neuronal cell bodies (d). No GP mRNA is present
in the axons of the ventral spinal nerve (e). The arrow in d points to mRNA in the initial segment of a process. Bar in a= 20 μm and applies to a-e.
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of GS and about 50% of that found in APC. Because of
the possibility that GP mRNA in NPC might be due to
the presence of contaminating astrocytes in NPC, glial
fibrillary acidic protein (GFAP) mRNA expression wasFigure 3 FISH detection of GS mRNA in cortical neuronal cultures, 4 D
with MAP 2 in dendrites (a-c) and tau in axons. (d-f). Higher magnification
dendritic and axonal processes. FISH for GS mRNA combined with GAP 43
cones is not obvious (g-i). j-l Negative control applying sense probe in com
Bar in g = 10 μm and applies to g-i. Bar in 1 = 5 μm, bar in 2 = 10 μm.determined as an approximate measure for the percentage
of astrocytes in the culture. Immunocytochemical analysis
of NPC with GFAP antibody routinely reveals a percentage
of 10–20% of contaminating astrocytes. GFAP mRNA ex-
pression in NPC was 0.19 fold of that of APC confirmingIV. GS mRNA is prominent in neuronal cell bodies and colocalizes
(1 and 2) of the boxed areas in c and f reveals mRNA clusters in
ICC reveals both signals in the axon, but colocalization in growth
bination with MAP 2 ICC. Bar in a = 20 μm and applies to a-f and j-l.
Figure 4 Upper panel (a-i): Detection of GP mRNA in cortical neuronal cultures, 6 DIV. Combination of GP FISH with MAP 2 ICC reveals a
weak FISH signal (a-c). d-f Negative control applying sense probe combined with MAP 2 ICC. g-i GP FISH combined with GFAP ICC. The arrows
point to a GFAP positive astrocyte not expressing GP mRNA. Lower panel (j-o): Detection of GP protein in cortical neuronal cultures, 6 DIV.
Double-labeling for GP with MAP 2 (j-l) reveals a weak signal for GP similar to that in the negative control (m-o). Co-staining with rabbit normal
serum in combination with MAP 2 antibodies indicates background staining level. Bar in a = 10 μm and applies to a-c, bar in d = 20 μm and
applies to d-i, bar in j = 10 μm and applies to j-o.
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blotting clearly demonstrated the presence of GP protein in
NPC (Figure 5b).
GP FISH and IHC on cultured trigeminal neurons and
trigeminal ganglion sections
As a representative of peripheral sensory neurons, we
investigated trigeminal neurons. These neurons expressed
GP protein (Figure 6a-c). The signal was present in the cell
soma. Especially in large neurons, the signal was also detect-
able in processes (arrows in Figure 6a-c). GP mRNA, how-
ever, was abundant in the cell soma but not detectable in
the cell processes. This holds true for cultures derived frompostnatal ganglia (Figure 6d-f) as well as for cultures derived
from embryonic ganglia (Figure 6g-i). Likewise, GS mRNA
is detectable in the soma but not in precesses (Figure 6j-l).
In sections from adult trigeminal ganglia, GP mRNA and
protein could be detected in neuronal soma (Figure 7a-c),
whereas in trigeminal nerve the protein but not the mRNA
was discovered (Figure 7d-f). The nuclear signal observed in
Figure 6j for GS mRNA and in Figure 7a for GP mRNA is
probably due to pre-mRNA in nuclear speckles.
Discussion
mRNA localization to neuronal processes has primarily
been described for proteins belonging to the categories
Table 1 Summarized results of FISH and ICC/IHC studies on cultured neurons and tissue sections
GP mRNA GS mRNA GP protein
MNC soma and processes soma and processes soma and processes
motoneurons in spinal cord positive data not shown positive
ventral root of spinal nerve negative data not shown positive
NPC low signal level, data not significant soma and processes low signal level, data not significant
TGC soma soma soma and processes
neurons in trigeminal ganglion positive data not shown positive
trigeminal nerve negative data not shown positive
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molecules and nuclear factors. It was the aim of this
study to investigate by FISH techniques whether the
mRNAs for glycogen synthase and glycogen phosphorylase,
the key players in glycogen metabolism and, consequently,
major enzymes of energy metabolism are also transported
to axons and dendrites. The occurrence of mRNA targeting
in neurons could shed light on the still controversially
discussed functions of glycogen in nervous tissues. The
sites of glycogen synthesis, storage and metabolism have
been under debate till now: In the CNS, glycogen is mainly
stored in astrocytes [6,21] though under stressful conditions
like trauma and fasting [6] or in hibernating animals
[22] it could also be demonstrated in neurons. Likewise,
the presence of glycogen-metabolizing enzymes in the
CNS has been described in astrocytes [23-25] but also
in cortical neurons [23] and in distinct types of neurons
in the brain stem and spinal cord [13]. In contrast to the
CNS, glycogen in the PNS has not been studied system-
atically. Recently, it has been demonstrated in Schwann
cells of myelinated axons of the sciatic nerve [12]. GP
immunoreactivity, however, was abundant in axons of
peripheral nerves [15].
We found that GP and GS mRNAs were present in the
cell soma of diverse cultured neurons but also in axonal
and dendritic processes, indicating that the subcellular
distribution of these mRNAs is regulated and that theseFigure 5 qRT-PCR studies and Western blot analysis. a GP, GS and GFA
rat cortex and cerebellum. Ct-values were normalized to GAPDH, β-actin an
relevant rates in astroglial cultures. Data were shown as means ± SEM (n =
whole rat brain and astroglial cultures. For each protein extract, 2,5 and 1 μmRNAs could also be translated in dendritic and axonal
compartments. However, we observed major differences be-
tween different types of cell culture, which is in accordance
with the significant variation between axonally localized
mRNAs found in various transcriptome analyses, e.g.
between intact and injured axons [3] or during develop-
ment from embryonic to adult [4]. In cultured spinal
cord motoneurons GP as well as GS mRNAs were localized
even to far-distant regions of processes (Figure 1). In con-
trast, no localization was evident in cultured trigeminal
neurons (Figure 6). Trigeminal neurons receive sensory
input from the facial skin and mucosae and are analogous
to DRG neurons that receive sensory input from the skin
in limbs and trunk. DRG neurons as well as spinal nerve
have been shown to express GP abundantly [15], and this is
also the case in the trigeminal ganglion and nerve (Figure 7).
Accordingly, trigeminal neurons contain GP protein in
their processes and should therefore be a probable can-
didate for mRNA localization, which was not observ-
able. This is in contrast to spinal cord motoneurons,
which are known to express GP protein though they are
part of the CNS. With their axons projecting to muscles,
however, they are also part of the PNS, and GP could
be demonstrated in axons of the ventral spinal nerves
(Figure 2). With GP protein present and with respect to
the appreciable length of trigeminal and spinal nerves,
both types of neurons would be considered probableP mRNA expression levels were analyzed in cortical neuronal cultures,
d 18S rRNA. Expression rates of the genes were given as n-fold of the
6). b GP protein Western blotting analysis in cortical neuronal cultures,
g of protein were loaded.
Figure 6 FISH detection of GP and GS mRNA in cultured trigeminal neurons. a-c ICC for GP combined with β-tubulin ICC. GP protein is
present in neuronal cell bodies and processes (arrows in a-c point to a long neuronal process expressing GP). d-f FISH for GP combined with
MAP 2 ICC, culture derived from postnatal trigeminal ganglia, 3 DIV. GP mRNA is abundant in neuronal cell bodies but absent from MAP 2
positive processes. g-i Same as in d-f, but cultures derived from embryonic ganglia, 2 DIV. GP mRNA is only present in neuronal cell bodies. j-l
Combination of GS FISH with MAP 2 ICC, cultures derived from PD 2 ganglia. GS mRNA is only present in cell bodies and nuclear speckles (j). Bar
in a = 10 μm and applies to a-c, bar in d = 10 μm and applies to d-f, bar in g = 20 μm and applies to g-i, bar in j = 20 μm and applies to j-l.
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was only the case for motoneurons. The difference
might be attributed to several factors. First, there are
principal differences between motoneurons and sensory
neurons. Motoneurons but not trigeminal neurons are
affected in severe diseases like spinal muscular atrophy
(SMA, [26]) or amyotrophic lateral sclerosis (ALS, [27,28]).
The vulnerability of these neurons might be due to the
length of their axons, which implies transport over
long distances. The molecular motors involved in these
transport processes require ATP. Fast axonal transport
is energized by glycolytic enzymes located on motile
vesicles rather than by mitochondrially produced ATP [29].
Glycolysis might be fueled by glucose, which could beprovided by a spatially controlled local GP translation
and subsequent glycogen degradation. For those neurons,
local GP and GS synthesis aided by GP and GS mRNA
localization might be especially favorable because it would
allow a fine-tuned energy supply. Second, the developmen-
tal states of neurons at the time point they were taken
in culture are different and reflect variable metabolic
requirements. In addition, culture conditions are not
identical. For example, spinal motoneuron cultures are
extremely pure cultures whereas TGC contain an appre-
ciable fraction of non-neuronal cells like Schwann cells and
fibroblasts, which contribute to growth and nourishment.
Local glycogen degradation in processes might therefore be
of lower importance. Third, mRNA localization depends on
Figure 7 GP FISH combined with GP IHC applied on sections of trigeminal ganglion and nerve. a-c trigeminal ganglion, d-f trigeminal
nerve. GP mRNA and protein is visible in the trigeminal cell bodies, trigeminal nerve shows no FISH signal but expresses GP protein. Bar in
a = 20 μm and applies to a-f.
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http://www.biomedcentral.com/1471-2202/15/70the interplay of diverse molecular motors [30] with the
superfamily of kinesin proteins playing an important
role [31]. Different types of kinesins are expressed in
different types of neurons, and lack of the correct kine-
sin might also account for the absence of GP and GS
mRNA localization in TGC.
Though GP and GS mRNAs are localized to processes
in spinal motoneurons under culture conditions, this
could not be demonstrated in situ by applying FISH on
tissue sections (Figure 2). This is not necessarily a discrep-
ancy, because neurons in culture encounter an artificial en-
vironment and are subject to factors and molecules quite
different from those in vivo. Also, mRNA localization plays
a major role in developmental processes like neuronal
maturation and axonal outgrowth (for overview, see [32])
implying a versatile mRNA distribution. Gumy et al.
reported on a dynamical change of localized mRNA
repertoires in explants cultures from embryonic to adult
[4]. Among the mRNAs only localized to axons in cultures
derived from embryonic tissues were also those for GPBB
and glycogenin, the self-glycosylating activity of glycogen
synthase. In addition, neurons in culture share properties
with regenerating neurons, which have mRNA spectra
different from uninjured cells [3]. Trigeminal neurons
do not localize GP/GS mRNA to their processes, nei-
ther in culture nor in situ. Whether conditions could
be found which would allow targeting, must be subject
of extended investigations.
Cortical neurons do not store glycogen but express GS
[23]. The enzyme is locked in an enzymatically inactive
state by an intricate enzymatic machinery. Failure of its
inhibition results in a severe neurological disorder named
Lafora disease that is characterized by the accumulation
of an atypical toxic glycogen [33]. GS mRNA has been
demonstrated in NPC by Northern blotting [34]. In ourstudies, FISH demonstrated GS mRNA presence in the
neuronal somata as well as in the processes of cultured
cortical neurons. This localization points to a function
of GS apart from synthesizing glycogen. In HeLa cell
ribosomes, GS has been shown to be involved in trans-
lational control [35]. Non-enzymatic functions for en-
zymes, a phenomenon called moonlighting, have been
described for many enzymes, among them glycolytic
ones [36]. Among those is another enzyme of the basic
carbohydrate metabolism, GAPDH, for which evidence
suggests a role in the fusion of vesicles to membranes
[37]. In contrast to GS, GP and its mRNA has previously
not been demonstrated in NPC [25,34]. This might be
attributed to technical reasons like low sensitivity of
the methods applied. Therefore, we used qRT-PCR and
Western blotting with chemiluminescence detection in
addition to FISH and ICC. The latter methods did not
lead to unequivocal results because the signal intensity
did not differ significantly from that reached in the
negative control experiments. qRT-PCR and Western
blotting, however, revealed the presence of GP mRNA
and protein in NPC. GP mRNA in NPC might be at-
tributed to contaminating astrocytes which, according
to immunocytochemical analysis and GFAP mRNA ex-
pression, can mount up to about 20%. These astro-
cytes, however,are not a probable source for GP mRNA
and protein because they do not express GP mRNA
(Figure 4g-i) and do not stain for GP protein [25]. This
might be due to the fact that for astrocyte primary cultures,
postnatal brains were used while neuronal cultures
were derived from embryonic brains. Astrocytes in the
latter culture might therefore be in a different state of
differentiation. Also, the presence of certain neurons
selected for by the culture conditions might influence
the expression of GP. Western blotting demonstrated
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http://www.biomedcentral.com/1471-2202/15/70the presence of GP protein in NPC, though in smaller
amounts compared to APC.
The question whether cortical neurons do express GP
could not be answered definitely by our investigations.
However, potent qRT-PCR analysis pleads in favor of GP
mRNA expression, and GP should be thought of as a pos-
sible additional player, though with a still enigmatic role.
Conclusions
We could show that the mRNAs for GS and GP, two
major enzymes of the metabolism of glycogen, the single
large energy reserve in neural tissues, can be localized to
neuronal processes. This might have important conse-
quences for neuronal functionality under energy de-
manding conditions like growing, repair and memory
consolidation. Because cultured spinal motoneurons were
the most impressive example for GS and GP mRNA
localization, a so far unknown role for glycogen in these
neurons with their far-reaching processes should be dis-
cussed. In contrast to peripheral neurons, cortical neurons
do not store glycogen under non-pathological conditions
but express GS, and, as shown in our studies, do localize
its mRNA to neuronal processes. This may indicate a
moonlighting function for GS.
The results of our investigations are another jigsaw in
the glycogen puzzle. To approach the functional role(s)
of glycogen in peripheral neurons, metabolic studies are
now of high importance.
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